Commentary

Article

State of the Science Summit - Hematologic Malignancies: Chaired by Jennifer Amengual, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Jennifer Amengual, MD

State of the Science Summit - Hematologic Malignancies: Chaired by Jennifer Amengual, MD

Speakers

  • Joseph G. Jurcic, MD | Columbia University Herbert Irving Comprehensive Cancer Center
  • Sunil Iyer, MD | Columbia University Herbert Irving Comprehensive Cancer Center
  • Andrew H Lipsky, MD | Columbia University Herbert Irving Comprehensive Cancer Center
  • Hua-Jay J Cherng, MD | Columbia University Herbert Irving Comprehensive Cancer Center

Topics

  • Treatment of patients with myelofibrosis
  • Emerging treatment standards for MDS
  • Use of BTK inhibitors in MCL and CLL
  • Bispecific antibodies in DLBCL
  • Top 5 abstracts from ASH 2023

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science SummitsClick here to listen to our latest episodes!

Related Videos
Timothy Hughes, MD, MBBS, FRACP, FRCPA
Ben Levy, MD, and Yan Leyfman, MD
BTK Inhibitors in CLL : Second Generation Drugs and Beyond
Carrie L. Kitko, MD
Lori A. Leslie, MD
Lori A. Leslie, MD
Changchun Deng, MD, PhD
Guenther Koehne, MD, PhD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University